M. Frank Erasmus BS, MS, PhD

M. Frank Erasmus is a postdoctoral research scientist. Frank is a Ruth L. Kirschstein research fellow with the National Cancer Institute for his work involving the pre-B cell receptor in acute lymphoblastic leukemia. He brings over 8 years of experience in the development and characterization of therapeutic antibodies in the academic and industry environments. Within industry, he worked as an analytical chemist to characterize antibody-based products in a cGMP/GMP facility.
As a predoctoral trainee at the Spatiotemporal Modeling Center of New Mexico and Los Alamos National Labs, he incorporated both experimental and computational approaches to develop antibody-based products for treatment in leukemia. Frank is a co-inventor of a patented antibody therapy that he recently adapted for use as a chimeric antigen receptor (CAR) T cell therapy in acute lymphoblastic leukemia. He holds a Ph.D. in Biomedical Science (University of New Mexico), an M.S. in Molecular & Cell Biology (San Diego State) and a B.S. in Molecular Biology (Cal Poly, San Luis Obispo).